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Abstract S phase entry, I.e. start of DNA replication, Is a cru- 
cial step in proliferation. Inhibition of S phase entry correlates 
with Inbibition of hypusine formation, an event affecting only the 
eukaryotie Initiation factor $A (elF4A), Its hypuslnecontalning 
sequence wus postulated to authorize polysomal utilization of 
specific trauscripts for proteins necessary to enable DNA replica- 
tion. Using ndmodne to reversibly suppress the hyposinc-forming 
deoxyhypusyi hydmxylase (E.C. 1.1¢99.29) in cells while differ- 
entially displaying their polysomal versus non-polysemal mRNA 
popolations, we report he detection and cla~!fleation of several 
mRNA species that indeed isappear f om and reappear at !lo1- 
ysomes in con~rt with inhibition and d_!s!nhibition, respectively, 
of hypusine formation. Based on initial sequence data, two traus- 
lationally controlled enzymes, both critical for proliferation, are 
identified us candicate wodncts of such mRNAs, methionine 
adenosyitrausferuse (E.C 2.$.1.6) and cytochrome-c oxiduse 
0gC 1.9.3.1) subunit 1. The existence of such potative hyposine- 
dependent messenger nnclde adds (/O, mas) prevides the basis for 
a proposal on their molecular function in onset of multiplication. 
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I, Introduction 
The unique amino acid hypusine [~-(4-amino-2(R).hy- 
droxybutyl)-t.-lysine] is formed post-translationally by the se- 
quential action of deoxyhypusyl synthase (DOHS) and de- 
oxyhypusyl hydroxylase (DOHH) on a single lysyl residue in 
only one cellular protein, the eukaryotic initiation factor 5A 
(elF-SA) [I-3]. The hypusine-containing domain shows re- 
markable interspecies conservation, and a sequence of 12 
amino acids containing the hypusine residue has been strictly 
conserved throughout eukaryotic evolution, from fungi to 
plants, insects, and mammals [3]. Hypusine formation, which 
has not been demonstrated in prokaryotes [2], is an absolute 
requirement for growth of $. cerevesiae [4], and a number of 
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reports have established correlations between hypusine forma- 
tion and the proliferation of eukaryotic ells (see [2,3]). How- 
ever, the exact physiological function of this presumed transla- 
tion initiatic~n factor is unknown, and at present it even is 
unclear whether elF-SA functions at the pretranslational and/ 
or the translational level [3]. 
Deoxyhypusyl hydroxylase (E.C. 1.14.99.29), which catalyses 
the final step of hypusine biosynthesis, is apparently related 
[5,6] to other protein hydroxy]ating enzymes uch as prolyl 
4-hydroxylase (E.C 1.14.11.2) [7] and is effectively inhibited by 
mimosine (3-(N-(3-hydroxypyridin-4-one))-2[S]-aminopropi- 
onic acid), both in vitro and in culture [3]. This coincides with 
proliferative arrest in the late GI phase ofthe cell cycle [3,8-11]. 
Fast recovery ofcellular DOHH activity occurs upon mimo,,;ine 
removal, an effect paralleled by passage of the G I-S boundary; 
in CHO cells, within 120 min hypusine levels recover to 50% 
of controls and S phase is entered in a highly synchronous 
manner [3]. Mimosine blocks S phase ntry by interfering with 
the initiation of DNA replication, and its removal is followed 
by rapid re-initiation of replication; in LAZ463 cells, bromode- 
oxyuridine incorporation increases as early as 30 min after 
deblocking, when conventional flow cytometry (CFC) does not 
yet detect S phase traverse [9]. After 60 min in inhibitor.free 
medium, with CFC still not revealing resumption of S phase 
entry, the levels of the proliferation-related mRNAs for 
phosphoprotein p53 and histone H4 already are changing in 
accord with their physiological lterations during G I-to-S tran- 
sit [3]. Re-addition of mimosine at that time no longer blocks 
GI-to-S passage in HL60 [8] or CHO cells (H.M.H-A., M. 
Lalande, unpublished observation), and S phase ntry and fur- 
ther cell cycle progression continue in the presence of previ- 
ously antiproliferative levels of mimosine [8]. 
These studies led to the proposal that the highly conserved 
hypusine-containing domain of elF-5A would act as a selector 
for a class of specific mRNA substrates, the polysomal utiliza- 
tion of which then provides the tools to start up the DNA 
replication machinery [3]. If this is the case, it follows that 
mRNA species exist which disappear and reappear at pol- 
ysomes in concert with inhibition arid disinhibition, respec- 
tively, of cellular hypusine formation. Therefore, we have com- 
pared the differentially displayed patterns of polysomai 
mRNAs isolated from control cells; from cells exposed to con- 
centrations of mimosine achieving both DOHH suppression 
0014-5793/95/$9.50 © 1995 Federation ofEuropean Biochemical Societies. All rights reserved. 
SSD!  0014-5793(95)00493-9 
H.M. Hanauske-Abel et al./FEBS Letters 366 (1995) 92-98 93 
and block in late GI phase; and from cells released from mi- 
mosine arrest for a just short, cytokinetically defined period. 
We report the detection and classification of a sub-set of 
polysomal mRNAs termed putative hypusine-dependent mes- 
senger nucleic acids (hymns) as they are associated with the 
mimosine-mediated modulation of hypusine formation and of 
GI-S transit. We identify two candidate hymn-related proteins 
and provide a conceptual framework for the mode of action of 
hymns. 
2. Materials and Methods 
2.1. Materials 
Mimosine was obtained from Aldrich, Milwau~ ee, WI. All chemicals 
and reagents were of the highest quality commercial'y available. 
Human lymphoblastoid YM-9 cells were from American Type Tissue 
Culture, Bethesda, MD. 
2.2. Cell culture and viability testing 
IM-9 cells were maintained in RPMI-1640 supplemented with 10% 
fetal calf serum and 2 mM glutamine inan atmosphere of 5% CO2/95% 
air at 37ec at a density ofabout 3x l0 s ceUs/ml. Viability was assessed 
by trypan blue exclusion and release of cytoplasmic LDH into the 
supernatant [6]. 
2..~. Determination f deoxyhypusine and hypusine 
Logarithmically proliferating IM-9 cells (500,000lml), in the absence 
or presence of400,uM mimosine, were labeled for 18 h with 5/~Ci/ml 
[terminal methylenes.3H]spermidine (31 Ci/mmoi; New England Nu- 
clear). Control and inhibited cells were immediately harvested [3]; the 
subset of the mimosine-exposed cells used to assess reversal of DOHH 
inhibition, was transferred into fresh, isotope- and inhibitor-free me- 
dium for 30 rain, and then processed [3]. 
2.4. Flow cytometry 
At the indicated times, samples containing 200,000 cells/ml were 
stained with acridine orange as described [12] and immediately analyzed 
on an Coulter Epics flow cytometer. 
2.5. Purification of mRNds 
Control, mimosine-blocked an  -deblocked IM-9 cells were washed 
twice in phosphate-buffered saline and re-centrifuged. The cell pellet 
was resuspended in 2 ml buffer (10 mM Tris-HCl, pH 7.4; 0.15 M KCi; 
4 mM MgCI2; 0.0005% Triton X-100) and lysed with a dounce homog. 
enizer. Nuclei were pelleted (2,000 rpm, 5 min), followed by centrifuga- 
tion to remove mitochondria (10,000 rpm, 15 min; Sorval SS34). The 
post-mitochondrial supernatant was adjusted to 0. ! % Triton X-100 and 
incubated at 4°C for 30 min to release membrane-bound polysomes. 
Polysomes, monosomes, and free RNA of each sample were then sepa- 
rated by centrifugation a linear 15-50% sucrose gradient in 30 mM 
Tris-HCl, pH 7.0, 100 mM NaCI, 10 mM MgCI2 (28,000 rpm, 4°C, 4 h; 
Beckman SW40.1). 0.7 ml fractions of this gradient were collected and 
the separation pattern monitored at254 nm. Fractions representing the 
three peaks obtained were pooled and concentrated byprecipitation 
using two volumes of ethanol. After 12 h at -20°C, the precipitate of
each pool was harvested by centrifugation (10,000 rpm, 40C, 15 min; 
Sorval SS34) and resuspended in 4M guanidinium isothiocyanate. The 
total RNA obtained per peak was then isolated by the cesium chloride 
step-gradient method [13]. The purified polysomal, ribosomal, or free 
RNA of each sample was dissolved in diethyl pyrocarbonate-treated 
water, quantified, and equal quantities applied in the differential dis- 
play assay. 
2.6. Differential display of mRNA samples 
To simultaneously visualize the mRNAs of relevant samples, the 
RNAmap kit (GenHunter, Boston, MA) was used. This technique 
involves (i) reverse transcription with oligo-dT primers anchored tothe 
start of the poly(A)tails of the mRNAs in the sample; (ii) subsequent 
PCR amplification i  the presence ofa second oligonucleotide of arbi- 
trary sequence; and (iii) electrophoretic separation ofthe [0~-3SS]dATP - 
labeled eDNA products on a 6% polyacrylamide g lunder denaturing 
conditions [14,15]. 
2.7. Cloning, sequencing, and identification fdifferentially displayed 
bands 
Bands of interest -were reamplii~d~ ushig the primer sets and PCR 
conditions specified for the RNAmap kit. These PCR products were 
immediately cloned employing the pCR-TRAP) cloning system 
(GenHunter, Boston, MA). The MAX Efficiency DHIOB) strain of 
competent E. coli (Gibco, Gaithersburg, MD) was used for transforma- 
tion. Plasmids were prepared by boiling method and sequenced using 
the Sequenase V rsion 2.0 kit (Amersham-USB, Cleveland, OH). Re- 
sults were referenced against the non-redundant nucleotide sequence 
databases of the National Center for Biotechnology Information 
(NCBI) using the BLAST program 
3. Results and discussion 
In investigating the postulated existence of mRNA species 
that depend on eIF-5A for selective translation of proteins 
gating S-phase entry and onset of DNA replication [3], we 
defined three operational criteria to guide the experimental 
identification ofsuch candidate transcripts. Biochemically, Cri- 
terion I requires that in cells subjected to complete suppression 
of hypusine formation, certain mRNAs selectively disappear 
from the polysomes. Criterion l! specifies that these mRNAs, 
denied polysomal localization in parallel with inhibition of 
DOHH, relocate in (i) both the monosomal nd free mRNA 
pools [IIa]; (ii) in only the monosomal [Ilb] or the free tile] 
mRNA pool; or (iii) they completely disappear [IId]. In each 
case, however, Criterion i l l  demands that such mRNAs re- 
occur at the polysomes of cells within a critical, brief period 
after their DOHH is reactivated and before Gl-to-S transit 
resumes. The disappearance (Criterion I) and re-appearance 
(Criterion III) of polysomal mRNAs coincident with suppres- 
sion and resumption of DOHH activity, respectively, is used to 
define these transcripts as putative hypusine-dependent mes- 
senger nucleic acids (hymns). Criterion II is only used for their 
categorization. Cytokinetically, Criterion I requires demonstra- 
tion of complete arrest in late GI, Criterion III is satisfied by 
evidence for imminent exit from G I not yet detectable by CFC. 
All three criteria must be met independent of the technique used 
for inhibition of cellular hypusine formation. Differential splic- 
ing could cause assignment of the same putative hymn to more 
than one class. 
By definition, Class IIa-d putative hymns are translationally 
expressed ina manner dependent on hypusine synthesis, rather 
than on transcription. In every other regard, however, these 
transcripts must be very diverse; for example, IId hymns by 
definition are instable and may display rapid degradation mo- 
tifs, whereas IIa hymns by definition are stable, but translation- 
ally masked. IIb and IIc hymns also are defined as translation- 
ally masked though present in monosome or free form, respec- 
tively. It is significant to caution that Criteria I-III are defini- 
tions, i.e. not contaminated byany concern for the actual bio- 
logical function of the eventual protein products. Such func- 
tion, however, may very well impact on the identification proc- 
ess applying Criteria I-III. If, for example, one of these protein 
products hould itself act by facilitating the translation of other 
mRNAs, which a priori cannot be ruled out, then Criteria I-IIl 
will rank these other mRNAs among the putative hymn tran- 
scripts, although their dependency on hypusine formation is 
indirect only. Irrespective of whether Criteria I-Ill-defined 
transcripts are directly or indirectly dependent on hypusine 
formation, identification of each putative hymn must reveal 
translational regulation of its expression, and its enabling role 
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Fig, !, Simultaneous determination in control (panel A), mimosine-blocked (panel B), and 30 min de-blocked (panel C) IM-9 cells of.' (i) cell cycle 
distribution; (ii) hypusine-to-deoxyhypusine conversion; and (iii) the polysomal, monosomal, and free mRNA pools, 
in multiplication. For classification as definitive hymn. addi- 
tional experiments need to demonstrate that each putative 
hymn meets these essentials: (i) direct interaction with eIF-SA; 
(ii) DOHH-dependent translation of its encoded protein; and 
(iii) activity of this encoded protein in S phase inlet events. 
Therefore, Criteria l-H! are necessary, but not sufficient o 
establish the directly hypusine-gated events in translation and 
in G! exit, 
The chemicals currently available for reversible inhibition of 
hypusine synthesis, and thus for applying Criteria I-III, may 
have multiple, mechanisticaily-unreiated, confounding effects 
on the complex cascade of cell cycle progression. Among these 
agents, only mimosine has been investigated in sufficient enzy- 
mological and cytokinetic detail to be used with confidence in
experiments probing Criteria l-IIl. Mimosine and mimosine- 
like compounds directly interact with the active site of DOHH 
il~ vitro [3,5,6]. Complete suppression of cellular hypusine for- 
mation, without affecting biosynthesis of the peptidyl de- 
oxyhypusine precursor and without overt cytotoxicity, is 
achieved within 16--18 h after addition of 200-500 pM mimos- 
ine, depending on cell type, and this effect coincides with arrest 
ofexit from the GI phase [3,8-11]. After mimosine removal, the 
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Fig. 2. Differential display of purified mRNA pools outlined in Fig. I. A 5'-TI2MC-Y primer anchored to the 5'-boundary ofthe poly(A) tails was 
used for reverse transcription, followed by PCR amplification with a second 10-mer of arbitrary sequence (Panel 1, 5'-AGGTGACCGT-Y; panel 
2, 5'-GACCGCTTGT-Y; panel 3, 5'-GGTACTCCAC-Y) [14,15]. The asterisk indicated the band segment that was reamplified, cloned, and 
sequenced in an effort to gain information on translationability. Left, autoradiographic bands of [~-3SS]dATP-labeled cDNAs obtained from the 
following mRNA pools: polysomal, of control cells (p Co); polysomal/monosomal/free, of c lls incubated with mimosine, to give complete inhibition 
of the hypusine-forming enzyme deoxyhypusyi hydroxylase, DOHH (p/m/f Mimosine); and polysomal, of cells released for 30 min from mimosine- 
mediated deoxyhypusv! hydroxylase inhibition, to allow for recovery ofenzyme activity (p R30'). Right, schematic highlight ofeach autoradiography 
identifying Criterion I (t:anscript disappearance from polysomes upon DOHH inhibition) and Criterion III (transcript reappearance at polysomes 
upon DOHH disinhibiti,:,n), and classifying each band according to Criterion lla-lld (transcript distribution upon DOHH inhibition). 
deoxyhypusine-to-hypusine co version swiftly resumes [3], and 
within less than l h re-initiation of DNA replication becomes 
detectable [9], the deblocked cells thereafter rapidly progressing 
into S phase in a synchronized manner [3,8-1 l] and returning 
to asynchronous proliferation in later cell cycles (H.M.H-A., 
L.S.-C, unpublished observation). Several subsequent reports 
confirmed the suppressive effect of mimosine on G l exit [l 6-22] 
and on the initiation of DNA replication [23-26], and verified 
reversibility of these effects upon mimosine removal [22,24,25]. 
Consequently, we added mimosine to logarithmically growing 
cultures of IM-9 cells to inhibit DOHH until arrest at the GI-S 
boundary occurred, and then briefly released the cells from the 
mimosine block by transfer to fresh medium. Inhibited, re- 
leased, and control samples were monitored for viability, cell 
cycle distribution and hypusine formation. Viability of the mi- 
mosine-exposed populations did not differ from controls, as 
assessed by Trypan blue exclusion and release of cytoplasmic 
LDH (data not shown). Each population was used to isolate 
by sucrose gradient centrifugation a polysomal, a monosomal, 
and a free mRNA pool. The results are shown in Fig. !. When 
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compared to asynchronously logarithmically proliferating con- 
trois (Panel A), exposure to 400/~M mimosine for 16 h (Panel 
B) caused complete arrest of both transit of the G I-S boundary 
and of hypusine formation, the latter esulting in accumulation 
of deoxyhypusyl precursor. A marked increase in the relative 
size of the monosomal mRNA pool was also observed. This is 
interpreted to reflect a translationally quiescent, yet readied 
status of the reversibly nondividing population. 30 rain after 
removal of mimosine by transferring the cells i,to fresh me- 
dium (Panel C), this prominence of the monosomal mRNA 
pool persisted, and the cells were still arrested in G i and had 
not yet entered $phase, as documented byCFC. DOHH activ- 
ity, however, had resumed, and the deoxyhypusine-to-hypusine 
convenion had progressed to 12~ of the controls. Conversion 
continua to increase, reaching 40¢~ after 150 rain when S phase 
entry became vident by CFC (data not shown; [3]). The 30 
rain-release time point (R30 °) was used for analysis of pol- 
ysomai mRNAs, displayed side-by-side with samples from con- 
trol and mimosine-inhibited cells. 
Representative findings obtained by differential display 
[14,15,27] of these distinct subceilular mRNA populations are 
shown in Fig. 2, a novel application for this technique which 
until now has been used exclusively on total cellular mRNA to 
identify differentially expressed genes (e.g. [27-32]). The three 
panels show autoradiograms of [a-3SS]dATP-labeled cDNAs 
obtained from the following mRNA pools: polysomal, of con- 
trol cells (p Co); polysomal/monosomal/frce, of inhibited cells 
(p/m/f Mim~ine); and polysomal, of debiocked cells (p R30°). 
After purification of the particular mRNAs from the appropri. 
ate cells, reverse transcription was achieved with a 5°-TuMC-3 °
primer anchored to the Y-boundary of the poly(A) tails. The 
products were then subjected to PCR amplification, using a 
second 10-mer of arbitrary sequence. For panel I, this second 
10-mer was Y-AGGTGACCGT-Y; for panel 2, Y. 
GACCGCTTGT-3°; and for panel 3, Y-GGTACTCCAC-Y. 
The eDNA subpopulations obtained, representing the 3' ter- 
mini in the indicated mRNA pools, were distributed on a DNA 
sequencing el under denaturing conditions, and visualized. 
Clearly, the autoradiographs of panels 1, 2, and 3 show numer- 
ous bands for the polysomes of control cells, the polysomes of 
mimosine-inhibited cells, and the polysomes of cells deblocked 
for 30 min. Mimosine exposure, i.e. DOHH inhibition, for 16 
h resulted in the loss of only a few polysomal bangs relative to 
control polysomes (Criterion I), but did not affect he presence 
of these bands in the monosomai and/or free mRNA pool 
(Criterion lla-c). This finding confirms that mimosine does not 
stop mRNA synthesis in general [33]. Even if bands disap- 
peared from the polysomes (Criterion I) and also vanished from 
the cytoplasm (Criterion IId), certain bands reappeared within 
30 rain of release from mimosine (Criterion lID, as shown in 
panel 3 of Fig. 2. Thus, on the molecular level reversibility of 
hypusine formation (Fig. I, panel C) and polysomal relocaliza- 
tion of certain transcripts (Fig. 2, lanes p R30' in all panels) 
occur simultaneously and well before resumption of prolifera- 
tion can be detected. In a first approximation, we estimate that 
out of a total of up to 30,000 individual mRNA species in 
mammalian cells identifiable by the differential display tech- 
nique [14,15,28], the systematic application of Criteria I-III 
employing mimosine will detect about 150 distinct putative 
hymns. 
To establish that differentially displayed bands actually cor- 
respond to differentially translated mRNAs, the cDNA of the 
Class Ila double band in panel 1 was eluted, reamplified, 
cloned, and used for E. coli transformation. Following PCR 
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screening, two clones were sequenced and found to display an 
identical insert (Fig. 3A) containing the tolerably [28] mis- 
matched arbitrary primer sequence at one end, but lacking the 
oligo-dT primer sequence. Referencing against the NCBI data- 
bases produced high-scoring segment pairs for both cyto- 
chrome-c oxidase (EC 1.9.3.1) subunit I (COX-I, [34]) (N = 7.6 
e -~s) and for methionine adenosyltransferase (E.C. 2.5.1.6) 
(MAT, ref. [35]) (N = 7.0 e -~2) (Fig. 3B). Both COX-I and 
MAT, though encoded by mitochondrial and nuclear genes, 
respectively, show translational regulation of gene expression. 
In S. cerevisiae, COX-I translation by mitochondrial polysomes 
is differentially controlled via the nuclear-encoded protein 
NAM lp ~36]; in germinating wheat embryos, MAT translation 
by cytoplasmic polysomes occurs from stored mRNA and pro- 
ceeds unaffected by transcriptional inhibition [37]. Both COX-I 
and MAT also have key roles in cellular proliferation. Total 
COX-I transcripts are very low in quiescent cells, but increase 
rapidly with resumption of proliferation [38]. MAT activity 
directly correlates with doubling time [39]; MAT inhibition 
causes proliferative arrest [40]. While both proteins are transla- 
tionally regulated and function in multiplication, as postulated 
for any putative hymn, identification of their mRNAs as defin- 
itive hymn requires further experiments omeet he three essen- 
tials described above. 
The identification of a mitochondrial transcript among the 
putative hymns is unanticipated and suggests ome release of 
mitoehondrial polysomes occured uring douncing. This obser- 
vation points to a conceivable role of eIF-5A in directing the 
translation of some mitochondrial mRNAs via NAMIp, a 
nulear encoded protein which may be hypusine-dependent. 
Others also have observed a selective ffect of mimosine on 
critical components of proliferating cells. Under the conditions 
used here, mimosine was reported to abolish H l kinase activity 
by selectively suppressing the formation of polyadenylated 
mRNAs encoding two HI kinase components, cyclin A and 
cdc2; return of H 1 kinase activity became measurable 4 h after 
mimosine removal, and activity normalized within 24 h [41]. A 
selective limination of cyclin A, though at higher concentra- 
tions of mimosine, was noted before [20]. Using shorter expo- 
sure periods, published ata show mimosine to reduce cyclin 
A mRNA levels [22] and to decrease p34 cdc2 [21]. Cyclin A is 
required for entry into S phase and onset of DNA replication 
[42,43], and formation of the cyclin A/p34 cdo2 complex precedes 
the start of S phase [21,44]. Applying the nomenclature we 
propose, cyclin A and cdc2 mRNAs for these reasons might be 
identified among the putative class IId hymns. 
We have recently demonstrated that cellular DOHH also is 
reversibly inhibited, again in concert with GI exit, by exposure 
to certain mimosine fragments and either ciclopirox or tran- 
sient hypoxia (H.M.H.-A., L.S.-C., R.C. Grady, M.H. Park, 
and J.E. Folk; unpublished observation). The latter two meth- 
ods both are known to shut down G l-to-S transit [8,45-47] and 
replicon initiation [23,48,49]. These effects readily reverse in 
cultured cells, generating marked population synchrony 
[8,46,50-54]. The availability ofciclopirox and the employment 
of transient hypoxia will allow probing for Criteria I-III - 
defined hymns without reliance on mimosine. Such studies are 
in progress. 
The identification of a sub-set of polysomal mRNAs associ- 
ated with hypusine formation dt ~he GI-S boundary adds a 
novel aspect o the evolutionary conservation of peptidyl hypu- 
sine formation among eukaryotes and suggests that this ability 
is not just a peculiarity of protein chemistry. Rather, it points 
to a functional integration of elF-5A and certain ribonucleic 
acids that occurs in the initial stages of eukaryotic multiplica- 
tion. If this functional integration is disrupted, either via its 
protein or its nucleic acid component, hen the ability of a 
eukaryotic ell to control its prodferation should be compro- 
mised. 
It has been reported that elF-5A is specifically bound by the 
protein Rev of the human immunodeficiency virus type I (HIV- 
1) [55] and may be a crucial cellular cofactor for viral replica- 
tion [56]. Without Rev, viral mRNAs are defective in their 
translational capacity; they appear to require lF-5A for trans- 
lation [57]. Indeed, inhibition of hypusine formation in HIV- 
infected cells selectively reduces viral glycoprotein biosynthesis 
and shifts viral mRNA away from their polysomes (L. Andrus, 
P.S., B.S., S.Z., R.W. Grady, A.-R.H, H.M.H.-A., unpublished 
observation). These findings suggest that certain HIV mRNAs 
may be recognized as hymns by the cellular translation machin- 
ery. 
Experimental inhibitors of hypusine biosynthesis, atthe level 
of either formation or hydroxylation of deoxyhypusine, i.e. 
DOHS or DOHH, are antiproliferative for certain normal and 
cancer cell lines [3,58] and also for human smooth muscle cells 
obtained from coronary restenotic lesions [6]. Structurally sim- 
ple compounds able to interfere with hypusine synthesis are 
widely used already, and in each case were empirically found 
to modulate ukaryotic proliferation. Guazatin, which inhibits 
deoxyhypusine formation [59,60], has been marketed in Europe 
as an agricultural fungicide [61]. Mimosine has been extensively 
studied in Australian sheep as a defleecing agent [62]. Ci- 
clopirox, which as predicted [8] inhibits deoxyhypusyl hydrox- 
ylation, is widely employed clinically as an excellent opical 
fungicide [63], its analog piroctone is a cosmetically applied 
anti-dandruff agent [64], and the analog rilopirox under inves- 
tigation as an antimycotic [65,66]. AbeAdo, studied for its po- 
tential as an antiparasitic and antineoplastic compound, was 
proposed to exert its antiproliferative effect by depletion of 
elF-5A [67,68]. Selective inhibition of hypusine formation by 
improved agents, e.g. at the level of DOHS or DOHH, may 
provide ~iovel instruments for the analysis and the control of 
eukaryotic proliferation. 
The association of hypusine formation with a sub-set of pol- 
ysomal ribonucleic acids on the one hand, and with exit from 
the G 1 phase of the cell cycle on the other, is compatible with 
the postulate [3] that this unique residue permits elective trans- 
lation of mRNAs which encode proteins pecialized to initiate 
and enable ukaryotic proliferation. We propose the following 
concept for this functional integration of elF-5A with certain 
mRNAs: 
Key proteins orchestrating the initiation of DNA replication 
and of irreversible progression through the G I-S boundary, are 
encoded by hymns, transcripts whose translation depends on 
appropriate hypusine formation. The consensus tructure of 
hymns for interaction with the hypusme-containing domain of 
elF-5A is the job-starting box (JSB): JSB defines hymns. 
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